Eli Lilly and Sankyo’s CS-747 / Prasugrel for Acute Coronary Syndrome
October 25, 2004 by admin · Leave a Comment
On October 25, 2004 Eli Lilly and Company and Sankyo Company announced that a Phase 3 clinical trial comparing the antiplatelet agents prasugrel and Plavix™ is scheduled to begin later this year. The study, known as TRITON-TIMI 38, will include a reported 13,000 patients who are suffering acute coronary syndromes (heart attacks or unstable angina) [...]
Preos osteoporosis drug
April 2, 2004 by admin · Leave a Comment
On March 30, 2004 NPS Pharmaceuticals Inc. said that its Phase III osteoporosis drug, Preos, significantly reduced spinal fractures or worsening of fractures in a study of 2, 600 postmenopausal women. The 18-month study on Preos involved postmenopausal women with mild to moderate osteoporosis. 81% of participants had no previous history of vertebral fracture. The [...]